These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 1746455

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase.
    Morris JA, Muller DW, Topol EJ.
    Am Heart J; 1991 Aug; 122(2):375-80. PubMed ID: 1907086
    [Abstract] [Full Text] [Related]

  • 24. Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial.
    Ostermann H, Schmitz-Huebner U, Windeler J, Bär F, Meyer J, van de Loo J.
    Eur Heart J; 1992 Sep; 13(9):1225-32. PubMed ID: 1396833
    [Abstract] [Full Text] [Related]

  • 25. Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model.
    Lu HR, Lijnen HR, Stassen JM, Collen D.
    Blood; 1991 Jul 01; 78(1):125-31. PubMed ID: 1906351
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Multicenter dose-finding trial for thrombolysis with urokinase preactivated pro-urokinase (TCL 598) in acute myocardial infarction. German Preactivated Pro-Urokinase Study Group.
    Gulba DC, Bode C, Sen S, Topp J, Fischer K, Wolf H, Hecker H.
    Cathet Cardiovasc Diagn; 1992 Jul 01; 26(3):177-84. PubMed ID: 1617708
    [Abstract] [Full Text] [Related]

  • 28. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC, Tanswell P, Dechend R, Sosada M, Weis A, Waigand J, Uhlich F, Hauck S, Jost S, Rafflenbeul W, Lichtlen PR, Dietz R.
    J Am Coll Cardiol; 1997 Dec 01; 30(7):1611-7. PubMed ID: 9385884
    [Abstract] [Full Text] [Related]

  • 29. Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction.
    von Hodenberg E, Kreuzer J, Hautmann M, Nordt T, Kübler W, Bode C.
    Am J Cardiol; 1991 Jun 15; 67(16):1349-53. PubMed ID: 1828324
    [Abstract] [Full Text] [Related]

  • 30. Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.
    Van de Werf F, Nobuhara M, Collen D.
    Ann Intern Med; 1986 Mar 15; 104(3):345-8. PubMed ID: 3080936
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group.
    Grines CL, Nissen SE, Booth DC, Gurley JC, Chelliah N, Wolf R, Blankenship J, Branco MC, Bennett K, DeMaria AN.
    Circulation; 1991 Aug 15; 84(2):540-9. PubMed ID: 1907228
    [Abstract] [Full Text] [Related]

  • 34. Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS).
    Neuhaus KL, Tebbe U, Gottwik M, Weber MA, Feuerer W, Niederer W, Haerer W, Praetorius F, Grosser KD, Huhmann W.
    J Am Coll Cardiol; 1988 Sep 15; 12(3):581-7. PubMed ID: 3042835
    [Abstract] [Full Text] [Related]

  • 35. New developments in thrombolytic therapy.
    Collen DC, Gold HK.
    Thromb Res Suppl; 1990 Sep 15; 10():105-31. PubMed ID: 2180114
    [Abstract] [Full Text] [Related]

  • 36. Dose-ranging study with a new two-chain rt-PA in patients with acute myocardial infarction: a multicenter trial.
    DeWood MA, Kurnik PB, Jolly MK, Jain AC, Khaja F, Gorfinkel HJ, Morris DL, Satler L, LittleJohn J.
    Clin Cardiol; 1993 Apr 15; 16(4):302-10. PubMed ID: 8458110
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Randomised double-blind trial of recombinant pro-urokinase against streptokinase in acute myocardial infarction. PRIMI Trial Study Group.
    Lancet; 1989 Apr 22; 1(8643):863-8. PubMed ID: 2564949
    [Abstract] [Full Text] [Related]

  • 40. Enhanced myocardial salvage by maintenance of microvascular patency following initial thrombolysis with recombinant tissue plasminogen activator.
    Longridge DJ, Follenfant MJ, Maxwell MP, Ford AJ, Hughes B.
    Cardiovasc Res; 1990 Sep 22; 24(9):697-706. PubMed ID: 2121357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.